View drug registration information details.
| Items | Registration information |
|---|
| ID | 190 |
|---|
| No | 190 |
|---|
| Brand Name | APELIDX |
|---|
| Ingredients | ALPELISIB 150 MG |
|---|
| Dosage Form | FILM COATED TABLET |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 28'S/BOTTLE |
|---|
| Dispensing Category | |
|---|
| ATC Classification | |
|---|
| Pharmaceutical Class | |
|---|
| Indications | IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF POSTMENOPAUSUAL WOMEN, AND MEN WITH HORMONE RECEPTOR POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE, PIK3CA MUTED, ADVANCED OR METASTATIC BREAST CANCER. |
|---|
| Contraindications | |
|---|
| Side Effects | |
|---|
| Unit Price | |
|---|
| EDL |
NULL |
|---|
| Description | PINK TABLET |
|---|
| Note | |
|---|
| License Owner | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Manufacturer | BIGBEAR PHARMACEUTICAL LAO CO.,LTD |
|---|
| Country | LAOS |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | |
|---|
| FDD Registration No | 04 L 1330/25 |
|---|
| FDD Registration Date | 2025-04-21 |
|---|
| Expiry Date | 2030-04-20 |
|---|
Back to drug list
|
